Table 3.

Multivariate analysis of euDKA postoperatively up to 30 days

Variable	Odds ratio	95% CI	p-value
Age (years)	0.979	0.949–1.010	0.180
Male	1.202	0.467–3.091	0.703
BMI (kg/m2)	0.949	0.864–1.043	0.277
Discontinuation of SGLT2is for ≥ 3 days prior to surgery	0.047	0.006–0.353	0.003
Preoperative use of insulin and glucose infusion	0.054	0.007–0.408	0.005

BMI, body mass index; CI, confidence interval; SGLT2i, sodium-glucose cotransporter 2 inhibitor